• 한국응용과학기술학회지
• /
• 제29권2호
• /
• pp.311-316
• /
• 2012

우리는 순환전압전류법에 의한 LB 필름에 대한 전기화학적 특성을 조사하였다. 인지질 화합물은 ITO glass에 Langmuir-Blodgett법을 사용하여 제막하였다. 0.5, 1.0, 1.5 및 2.0 N $NaClO_4$ 용액에서 3 전극 시스템 (Ag/AgCl 기준전극, 백금선 카운터 전극 및 LB 필름이 코팅된 ITO 작업전극)으로 순환전압전류법을 사용하여 전기화학적 측정을 시도하였다. 측정 범위는 연속적으로 1650 mV로 산화시키고, 초기전위인 -1350 mV로 환원시켰다. 그 결과, 인지질 화합물의 LB 필름은 순환전압전류도표로부터 오직 산화전류로 인한 비가역공정으로 나타났다. LB 필름의 확산계수(D) 효과는 인지질 화합물 양의 증가로 인하여 감소하였다.

• 한국전기전자재료학회:학술대회논문집
• /
• 한국전기전자재료학회 2000년도 제2회 학술대회 논문집 일렉트렛트 및 응용기술전문연구회
• /
• pp.11-14
• /
• 2000

This paper describes a thennally stimulated displacement current(TSDC) of polyamic acid alkylamine salts(PAAS) Langmuir-Blodgett(LB) films, which is a precursor of polyimide(PI). The TSDC measurements of PAAS LB film were performed from room temperature to about $250^{\circ}C$ and the temperature was increased at a rate of $0.2^{\circ}C/s$. This show that this is TSDC peaks at about $70^{\circ}C$ in the arachidic acid LB films, and at about $70^{\circ}C$ and $160^{\circ}C$ in the PAAS LB films. Results of this measurements indicate that one small peak at $70^{\circ}C$ is resulted from a softening of the alkyl group and the large peak at $160^{\circ}C$ is possibly due to dipole moment of C-O group in the PAAS molecule. We have calculated the vertical component of dipole moment of the P AAS LB film out of the TSDC curves. It shows that the dipole moment of PAAS LB film is about -40mD at $70^{\circ}C$ and about 200mD at $160^{\circ}C$ in the first measurement of TSDC. In the second measurement of TSDC of PAAS LB film after cooling down to room temperature, the TSDC peaks are almost disappeared.

• 한국통신학회논문지
• /
• 제17권12호
• /
• pp.1391-1400
• /
• 1992

본 논문에서는 CCITT에서 ATM 망의 사용 감시 알고리즘에 대한 정확도의 평가 기준으로 고려하고 있는 type-I/II 에러의 평가방법을 제안하였다. 그리고, ON/OFF 트래픽 모델에 대한 LB(leaky bucket)방식의 type-I/II 에러 분석을 통하여 평균 셀률과 최대 셀률을 감시 제어하기 위한 LB파라 미터의 결정방법을 고찰하였다. LB파라미터인 계수기의 감소율 a와 한계치 M은 type-I 에러를 만족하는 a-M 특성곡선을 구한후, 이 중에서 type-II 에러를 만족하면서 반응시간이 최소가 되는 (a, M)의 쌍으로 결정할 수 있음을 제시하였다. 이때, ON/OFF 트래픽에 대한 LB방식의 a-M 특성곡선은 트래픽의 버스트성에 의해 결정되어 짐을 알 수 있었다. 그리고, 성능분석 결과로부터 LB 방식은 최대 셀률에는 비교적 좋은 제어 성능을 가지지만, 평균 셀률 제어에 있어서는 정확도와 반응시간과의 상반관계로 인해 문제가 있음을 알 수 있었다.

• 미생물학회지
• /
• 제36권1호
• /
• pp.74-78
• /
• 2000

본 연구에서는 Photobacterium phosphoreum의 배양 및 생체발광을 위한 최적 배지의 개발과 장기저장 후 생체발광능의 회복을 위한 최적의 저장 조건을 확립하고자 하였다. P. phosphoreum을 배양하기 위한 배지로 Luria broth(LB) 배지를 변형한 modified LB(mLB) 배지를 개발하였다. mLB 배지는 Luria broth에 1.5%의 NaCl과 3%의 글리세롤을 보정, 첨가한 배지로, 미생물 생장 및 생체 발광량이 Nutrient broth 배지보다 약 25% 가량 높은 수치를 보여주었으며, 생장 대수기에서 생장 휴지기로 넘어갈 때 생체 발광량이 최고치에 달하였다. 30% 글리세롤을 첨가하여 $-20^{\circ}C$ $-70^{\circ}C$ 및 액체질소에 3개월간 보관한 후, 배양하여 생장 및 생체 발광량을 조사한 결과에서는 $-20^{\circ}C$ 보관한 시료가 가장 좋은 결과를 보였다. 항 동결제로 5% adonitol을 첨가하여 동결 건조한 시료는 재 배양 시 adonitol를 첨가하지 않은 시료보다 16시간 이상 짧은 생장 유도기를 보여 주었고, 생체 발광량이 최고조에 달하는 시간도 빠르게 나타났다.

• 해양환경안전학회지
• /
• 제16권2호
• /
• pp.223-228
• /
• 2010

전 세계적으로 기후변화에 대응하기 위한 노력이 본격화되는 가운데, 그동안 관심이 적었던 항만으로부터의 탄소배출량이 상당량에 이르고 이의 억제를 위한 노력이 LA/LB(Los Angeles/Long Beach)항만을 중심으로 선진항만에서 전개되고 있다. 우리나라는 최근 Green Port 전략의 일환으로 부산항에서 저탄소 항만운영정책이 강화되고 있다. 저탄소 항만운영은 단기적으로 항만비용을 증가시켜 가격경쟁력을 약화시킨다. 따라서 부산항의 경우 저탄소 항만운영으로 인한 비용을 항만이용자에게 부담시키지 않고 항만당국이 저탄소를 위한 정책을 시행하고 비용을 부담하고 있다. 반면 LA/LB의 경우 저탄소 항만운영의 비용을 선주 및 화주 등 항만이용자에게 부담시키고 있다. 본 연구에서는 부산항과 LA/LB항의 저탄소 항만운영에 관한 비교분석을 통해 부산항의 지속가능한 항만운영의 시사점을 제시하였다.

• Biomolecules & Therapeutics
• /
• 제3권4호
• /
• pp.316-321
• /
• 1995

All the pharmacological studies of LB17522 described here were carried out with high doses (fifteen to sixty times of the therapeutic dose) to determine an indication of potential side effects in clinical use in terms of the acute clinical signs, cardiovascular and central nervous system. LB10522 does not produce any observable clinical signs except for the symptoms such as moist eye, skin rash, slight salivation, vomitting, and slightly reduced activity. The effects of LB10522 on the hemodynamics and cardiac function of anesthetized beagle dogs are as follows; heart rates and mean arterial blood pressure had a tendency to increase mildly, which is a normal finding in anesthetized dogs. All the animals except for one showed relatively stable respiratory rates throughout the observation period. Each animal treated with LB10522 showed slight increase in the left cardiac work and left ventricular stroke work which are mainly related to corresponding increases in cardiac output. Femoral blood flow were shown to be increased in some animals treated with LB10522. The epileptogenic activities of various cephalosporins were assessed by a direct intracerebral injection of appropriate concentration of test articles. The CD$_{50}$ values (nmol) obtained from the analysis of the dose-response data are as follows; 78.2, 175.3, 156.3, and 53.5 for cefazolin, cephaloridine, ceftazidime, and LB 10522, respectively. LB10522 seems to be equipotent with cefazolin or to be three times more potent than cephaloridine and ceftazidime in causing adverse CNS stimulation. Taken into consideration all the information obtained, LB10522 is not supposed to induce much changes in the functions examined in these studies in man at therapeutic doses.s.

• Biomolecules & Therapeutics
• /
• 제3권4호
• /
• pp.322-326
• /
• 1995

General pharmacology of LB20304, a quinolone antibiotic, were examined in terms of general behaviour, cardiovascular, and central nervous system. LB20304 at oral dose of 2,000 mg/kg did not induce significant behavioural changes in mice. In contrast with ciprofloxacin, LB20304 at dose of 20 mg/kg, iv. did not show any observable effects on the blood pressure in rats. Displacement of [$^3$H]muscimol binding to the rat brain synaptic membranes was measured. LB20304 was shown to be about five times less potent than ciprofloxacin in specific GABA receptor binding. Drug interaction between LB20304 and 4-biphenyl acetic acid, an active metabolite of fenbufen, was assessed in mice by measuring convulsion and/or subsequent death. A single oral pretreatment with 4-BPA at 400 mg/kg increased the incidence of convulsion and death after oral administration of ciprofloxacin at the doses of 25, 50, and 100 from zero of five to three of five, two of five, and four of five, respectively, whereas LB20304 alone or combination with 4-BPA caused neither convulsions nor death at the doses of 12.5, 25, 50, and 100 mg/kg, respectively. Quinolones-induced epileptogenic activities were assessed by a direct intracerebral injection of test articles. The CD$_{50}$ values (nmole) are as follows; 169.47, 35.36, 105.29, and 88.67 for LB20304, ciprofloxacin, of loxacin, and lomefloxacin, respectively. From these data, LB 20304 at therapeutic doses seems to be much more safe than any other quinolones tested.d.

• Biomolecules & Therapeutics
• /
• 제7권3호
• /
• pp.271-277
• /
• 1999

Safety evaluation of LB71350, a new HIV-1 protease inhibitor, was performed in mice, rats and dogs. For the general behavior of mice, LB71350 at an oral dose of 200 mg/kg did not show any significant effects on muscle tone and locomotor activity. In terms of central nervous system, at oral doses of 200 mg/kg and 1000 mg/kg, LB71350 inhibited acetic acid-induced pain response approximately 41% and 83% of control. respectively. At oral doses of 200 mg/kg and 500 mg/kg, it reduced the rectal body temperature in rats. Pentylenetetrazole-induced seizure in mice was slightly potentiated by oral administration of LB71350 at doses ranging from 200 mg/kg to 1000 mg/Ag. Single or five day treatment of LB71350 doubled the hexobarbital- induced sleeping time in mice at oral doses ranging from 50 mg/kg to 500 mg/kg. It did not cause any effects on gastric secretion and acidity in rat at oral doses of 200 mg/kg and 1000 mg/kg and also it did not change intestinal motility in mice up to 1000 mg/kg. Blood coagulation indices such as prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT) in rats were not affected by the treatment of LB71350 up to 500 mg/kg. LB71350 caused no significant effects on the cardiac output, stroke volume, heart rate, and mean blood pressure when infused intravenously to the anesthetized rats and dogs. Taken together, LB71350 at high oral doses caused significant pharmacological effects on the central nervous system and the hexobarbital-induced sleeping time.

• 대한치과교정학회지
• /
• 제49권2호
• /
• pp.73-80
• /
• 2019

Objective: The purpose of this study was to compare the static (SFF) and kinetic frictional forces (KFF) of a computer-aided design and computer-aided manufacturing lingual bracket (CAD/CAM-LB) with those of conventional LB (Con-LB) and Con-LB with narrow bracket width (Con-LB-NBW) under 3 tooth displacement conditions. Methods: The samples were divided into 9 groups according to combinations of 3 LB types (CAD/CAM-LB [Incognito], Con-LB [7th Generation, 7G], and Con-LB-NBW [STb]) with 3 displacement conditions (no displacement [control], maxillary right lateral incisor with 1-mm palatal displacement [MXLI-PD], and maxillary right canine with 1-mm gingival displacement [MXC-GD]; n = 6/group). While drawing a 0.016-inch copper or super-elastic nickel-titanium archwire with 0.5 mm/min for 5 minutes in a chamber maintained at $36.5^{\circ}C$, SFF and KFF were measured. The Kruskal-Wallis method with Bonferroni correction was performed. Results: The Incognito group demonstrated the highest SFF, followed by the 7G and STb groups ([STb-control, STb-MXLI-PD, Stb-MXC-GD] < [7G-MXC-GD, 7G-MXLI-PD, 7G-control] < [Incognito-MXLI-PD, Incognito-control, Incognito-MXC-GD]; p < 0.001). However, there were no significant differences in SFF among the 3 displacement conditions within each bracket group. Within each displacement condition, the Incognito group demonstrated the highest KFF, followed by the 7G and STb groups ([STb-control, STb-MXLI-PD] < Stb-MXC-GD < 7G-MXLI-PD < [7G-control, 7G-MXC-GD] < [7G-MXC-GD, Incognito-MXLI-PD, Incognito-control] < [Incognito-control, Incognito-MXC-GD]; p < 0.001). MXC-GD exhibited higher KFFs than MXLI-PD in the same bracket group. Conclusions: The slot design and ligation method of the CAD/CAM-LB system should be modified to reduce SFF and KFF during the leveling/alignment stage.

• Archives of Pharmacal Research
• /
• 제19권4호
• /
• pp.317-320
• /
• 1996

The time-kill curves of LB20304, a novel fluoroquinolone that has potent antibacterial activity against gram-positve and gram-negative bacteria, were calculated at the concentrations of 1/4-, 1/2-, 1-, 2- and 4-times the MIC against Staphylococcus aureus 77, Escherichia coli 3739E, Pseudomonas aeruginosa 1912E. The bactericidal activity of LB20304 for these strains was very rapid and comparable to that of ciprofloxacin. LB20304 produced a decrease in the $log_10$ CFU per milliliter of${\geq}$3 within 2 h at 4-times the MIC for all strains and consitently prevented regrowth of bacteria after 24 h of incubation. The MBCs (Minimal Bactericidal Concentration) of LB20304 against test organisms were equal to or at most four-times higher than the MICs.